Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran

Journal of Thrombosis and Thrombolysis

Volumn 25, Issue 3, 2008, Pages 280-283

  Rahimi, Zohreh ^a,b   Vaisi Raygani, Asad ^b   Mozafari, Hadi ^a   Kharrazi, Hadi ^b   Rezaei, Mansour ^b   Nagel, Ronald L ^c  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Factor V Leiden; Prevalence; Prothrombin G20210A; Western Iran

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; GUANINE; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNIC GROUP; ETHNICITY; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; IRAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ADULT; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRAN; MALE; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTHROMBIN; THROMBOPHILIA;

EID: 44649129978     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0052-6     Document Type: Article

References (19)

1. Endler G, Mannhalter C (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330:31-55
2. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
3. Ridker PM, Golhaber SZ, Danielson E et al (2003) Long warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348:1425-1434
4. Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-therm prevention of recurrent venous thromboembolism. N Engl J Med 349:631-639
5. Said JM, Brennecke SP, Moses EK et al (2006) Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population. Hum Biol 78:403-412
6. Awidi A, Shannak M, Bseiso A et al (1999) High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost 81:582-584
7. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY (2000) The prevalence of factor V R506Q mutation Leiden among apparently healthy Lebanese. Am J Hematol 65:45-49
8. Angchaisuksiri P, Pingsuthiwong S et al (2000) Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Hematol 65:119-122
9. Rees DC, Cox M, Clegg JB (1995) World distribution of factor V Leiden. Lancet 346:1133-1134
10. Zeinali S, Duca F, Zarbakhsh B, Tagliabue L, Mannucci PM (2000) Thrombophilic mutations in Iran. Thromb Haemost 83:351-352
11. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hemotology. The thalassemias, vol 6. Churchill Livingstone, London, pp 74-101
12. Bertina RM, Koeleman BPC, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
13. Zivelin A, Griffin JH, Xu X et al (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89:397-402
14. Lucotte G, Mercier G (2001) Population genetics of factor V Leiden in Europe. Blood Cells Mol Dis 27:362-367
15. Almawi WY, Keleshian SH, Borgi L et al (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis 20:163-168
16. Garewal G, Das R, Trehan U (1997) Factor V Leiden: Prevalence in the indigenous population and cases of thrombosis in north India. Br J Haematol 97:940
17. Abu-Amero KK, Wyngaard CA, Kambouris M, Dzimiri N (2002) Prevalence of the 20210G → A prothrombin variant and its association with coronary artery disease in a Middle Eastern Arab population. Arch Pathol Lab Med 126:1087-1090
18. Akar N, Misirlioglu M, Akar E, Avcu F, Yalcin A, Sozuoz A (1998) Prothrombin gene 20210G-A mutation in the Turkish population. Am J Hematol 58:249
19. Rosendaal FR, Doggen CJ, Zivelin A et al (1998) Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 79:706-708